EBR · ASX

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (ASX:EBR)

AU$1.58

 0.01 (0.635%)
ASX:Live
21/01/2025 04:10:16 PM
Volume Spike Near Resistance Near 52 Week High Hammer Bullish HALO Price Momentum +6
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

EBR Overview

EBR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About EBR

Website

N/A

Telephone

1.408.720.1906

Address

480 Oakmead Parkway Sunnyvale, CA 94085

Description

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. Its WiCS Wireless Cardiac Stimulation technology helps address the significant opportunity to eliminate cardiac pacing leads. The company was founded by Richard E. Riley and Debra Sheryl Echt in 2003 and is headquartered in Sunnyvale, CA.

EBR Price Chart

Key Stats

Market Cap

AU$551.05M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.67 - 1.61

Trade Value (12mth)

US$42,951.00

1 week

15.81%

1 month

57.5%

YTD

43.18%

1 year

120.42%

All time high

1.61

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

-$33m

Free Cash Flow Return

-48.70%

ROIC

-52.20%

Interest Coverage

-7.50

Quick Ratio

11.50

Other Data

Shares on Issue (Fully Dilluted)

311m

HALO Sector

Healthcare

Next Company Report Date

26-Feb-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

EBR Announcements

Latest Announcements

Date Announcements

21 January 25

CEO Investor Presentation

×

CEO Investor Presentation

20 January 25

EBR completes FDA PAI and update on FDA approval timing

×

EBR completes FDA PAI and update on FDA approval timing

20 January 25

WiSE accepted into new TCET reimbursement pathway of CMS

×

WiSE accepted into new TCET reimbursement pathway of CMS

08 January 25

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

07 January 25

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

06 January 25

Response to ASX Price Query

×

Response to ASX Price Query

06 January 25

FDA Pre-Approval Inspection Update

×

FDA Pre-Approval Inspection Update

03 January 25

Appendix 3Y

×

Appendix 3Y

03 January 25

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

27 December 24

EBR Systems Investor Roadshow

×

EBR Systems Investor Roadshow

23 December 24

EBR completes successful Day-100 PMA meeting with FDA

×

EBR completes successful Day-100 PMA meeting with FDA

19 December 24

EBR schedules Pre-Approval Inspection with the FDA

×

EBR schedules Pre-Approval Inspection with the FDA

16 December 24

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

13 December 24

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

11 December 24

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

06 December 24

EBR schedules Day-100 Meeting with the FDA

×

EBR schedules Day-100 Meeting with the FDA

27 November 24

Application for quotation of securities - EBR

×

Application for quotation of securities - EBR

27 November 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

13 November 24

Q3 2024 Quarterly Activity Report and Form 10-Q submission

×

Q3 2024 Quarterly Activity Report and Form 10-Q submission

07 November 24

Notification of cessation of securities - EBR

×

Notification of cessation of securities - EBR

06 November 24

Notification regarding unquoted securities - EBR

×

Notification regarding unquoted securities - EBR

29 October 24

Form S-8 Registration Statement

×

Form S-8 Registration Statement

25 October 24

Notice of Date for Q3 2024 Quarterly Report and Form 10-Q

×

Notice of Date for Q3 2024 Quarterly Report and Form 10-Q

22 October 24

Substantial Holding Notification

×

Substantial Holding Notification

17 October 24

Appendix 3Y

×

Appendix 3Y

EBR Fundamentals

Per Share Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.94 -0.12 -0.12 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.94 -0.12 -0.12 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A 87.0 1.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.09 -0.12 -0.11 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.54 -0.11 -0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 94.7 -34.1 6.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -87.9 -36.2 -28.3 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.28 0.16 0.10 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.28 0.16 0.10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 109.9 -42.7 -37.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 42 272 291 Lock Lock Lock
Basic m Lock Lock Lock Lock 42 272 291 Lock Lock Lock

Financial Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 22 33 34 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -55.9 -69.9 -15.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -22 -33 -34 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.1 -46.8 -2.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -23 -34 -35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.7 -47.2 -3.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -40 -33 -35 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -40 -33 -35 Lock Lock Lock
     Growth % Lock Lock Lock Lock -54.9 16.9 -5.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -22 -30 -33 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 1 1 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -1 -49 -9 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 96 17 40 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -23 -31 -33 Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.5 -34.8 -6.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 78 64 72 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 85 72 79 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 2 21 41 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -73 -42 -31 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 10 28 48 Lock Lock Lock
Equity $m Lock Lock Lock Lock 78 45 30 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 78 65 72 Lock Lock Lock
     Growth % Lock Lock Lock Lock 399.2 -16.4 10.9 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -46.6 -46.2 -44.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.8 -73.6 -116.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -57.6 -46.6 -51.3 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -144.2 -46.9 -52.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -80.2 -43.0 -48.7 Lock Lock Lock

Ratios Records

Historical data

Forecast data

USD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -1.2 -21.5 -7.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.3 1.3 0.9 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -93.7 -93.4 -101.7 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 11.1 11.2 11.5 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 11.1 11.2 11.5 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 96.5 95.4 97.2 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -302.8 -511.9 -507.1 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -46.6 -46.2 -44.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.6 2.6 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -50.8 -73.6 -116.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -50.8 -73.6 -116.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 839.3 1,054.6 934.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -839.3 -1,054.6 -934.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

EBR Shortsell

Frequently Asked Questions

The current share price of EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is AU$1.58.
The 52-week high share price for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is AU$1.61.
The 52-week low share price for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX)? is AU$0.67.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) does not pay a dividend.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) does not pay a dividend.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) has a franking level of 0.0%.
EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is classified in the Healthcare.
The current P/E ratio for EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh (EBR:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.